Issue Date | Title | Author(s) |
2020 | 158 Reconsidering the Threshold: Should Pulmonary Vascular Resistance >2 Wood Units be Considered Pulmonary Hypertension? | Lo, P; Kearney, K; Brown, K; Corrigan, C; Pidoux, A; Muthiah, K; Jabbour, A; Hayward, C; Macdonald, P; Kotlyar, E |
2023-07 | Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant | Song, N; Kearney, K; Phan, J; Kessler, C; Gorrie, N; Brennan, X; Deveza, R; Situ, Y; Kempton, H; Cherrett, C; Wiltshire, S; Conte, S; Tardo, D; Lo, P; Wong, N; Cao, J; Burrows, F; Carlos, L; Bart, N; Jabbour, A; Kotlyar, E; Keogh, A; Hayward, C; Macdonald, P; Muthiah, K |
2023-02-01 | Heart Transplantation From DCD Donors in Australia: Lessons Learned From the First 74 Cases. | Joshi, Y; Scheuer, S; Chew, H; Ru Qiu, M; Soto, C; Villanueva, J; Gao, L; Doyle, A; Takahara, S; Jenkinson, C; Vaidhya, N; Matsumoto, Y; Hwang, B; Zhao, C; Iyer, A; Connellan, M; Watson, A; Granger, E; Muthiah, K; Jabbour, A; Kotlyar, E; Keogh, A; Bart, NK; Hayward, C; Dhital, K; Jansz, P; Macdonald, PS |
2023-11-15 | Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices. | Chavali, S; Barua, S; Adji, A; Robson, D; Raven, LM; Greenfield, JR; Eckford, H; Macdonald, PS; Hayward, CS; Muthiah, K |
2023-03-29 | Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial. | Raven, LM; Muir, CA; Kessler Iglesias, C; Bart, NK; Muthiah, K; Kotlyar, E; Macdonald, P; Hayward, CS; Jabbour, A; Greenfield, JR |
2023-06-01 | Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction? | Bart, NK; Hungerford, SL; Namasivayam, M; Granger, E; Conellan, M; Kotlyar, E; Muthiah, K; Jabbour, A; Hayward, C; Jansz, PC; Keogh, AM; Macdonald, PS |
2023-12 | Major adverse kidney events predict reduced survival in ventricular assist device supported patients. | Barua, S; Conte, SM; Cherrett, C; Kearney, KL; Robson, D; Bragg, C; Macdonald, PS; Muthiah, K; Hayward, CS |